Top

BMC Cancer

Published in:

Open Access 01-12-2024 | COVID-19 | Research

Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil

Authors: Gilson Gabriel Viana Veloso, Flávia Duarte Amaral, Angélica Nogueira-Rodrigues

Published in: BMC Cancer | Issue 1/2024

Abstract

Background

There is no updated national data regarding the real impact of the COVID-19 pandemic on delaying diagnosis and treatment among patients with lung, and head, and neck cancers in Brazil. This study aimed to analyze the COVID-19 pandemic impact on cancer diagnosis and clinical outcomes among lung, head, and neck cancer patients assisted in a tertiary cancer center in Southeastern Brazil, as well as to analyze these patients’ pretreatment clinical features.

Methods

Retrospective cohort of patients with lung or head and neck cancer assisted in a tertiary cancer center in southeastern Brazil between January/2019 and December/2021. To assess statistical differences among groups [i.e., cohort 2019 versus (vs.) 2020 and 2019 vs. 2021] chi-square test was used with a 5% significance level and 90% power for sample size calculation. Differences among baseline clinical features and sociodemographic characteristics were evaluated either by T-test for two samples or Fisher’s or Pearson’s chi-square test (for quantitative or qualitative variables). All utilized tests had a 5% significance level.

Results

Six hundred fifty-two patients were included, 332 with lung and 320 with head and neck cancer; it was observed a significant decrease in oncologic treatment recommendations and increase in palliative care recommendation for patients with lung cancer, despite similar stages at diagnosis. During the COVID-19 pandemic, more pain symptoms were reported at the first Oncology assessment for patients with head and neck cancer (p < 0.05). Compared to 2019, head and neck cancer patients diagnosed in 2021 presented a worse initial performance status (p = 0.008). There was a statistically significant increase in survival for patients diagnosed with head and neck cancer in 2021 when compared to 2019 (p = 0.003).

Conclusions

This research highlights low survival rates for patients with lung and head and neck cancer in Brazil, even before the pandemic started, as consequence of advanced diseases at diagnosis at the public health system and clinical degrading features. Additionally, there was an increase incidence in both lung cancer and head and neck cancer despite no differences in clinical stage. This reflects how fragile is the public healthcare system even before facing an acute public health crisis such as the COVID-19 pandemic. Yet, the total impact on public health may follow for many years.

World Health Organization. Cancer. Available at: https://www.who.int/health-topics/cancer#tab=tab_1. Access 1 Feb 2023

World Health Organization. IAEA/WHO Joint Statement on Reducing Inequity in Access to Cancer Care through Rays of Hope Initiative. Available at: https://www.who.int/news/item/04-02-2022-iaea-who-joint-statement-on-reducing-inequity-in-access-to-cancer-care-through-rays-of-hope-initiative#:~:text=World%20Health%20Organization,expected%20to%20occur%20in%20LMICs. Access 1 Feb 2023.

Brasil. Instituto Nacional De Câncer (Brasil). Estimativa 2023: incidência de câncer no Brasil / Instituto Nacional De Câncer. – Rio de Janeiro: INCA; 2022. 160 p.: il. color.

World Health Organization. Coronavirus disease (COVID-19). Available at: https://covid19.who.int/. Access 1 Feb 2023.

Shah MA, Mayer S, Emlen F, et al. Clinical screening for COVID-19 in asymptomatic patients with Cancer. JAMA Netw Open. 2020;3(9):e2023121. https://doi.org/10.1001/jamanetworkopen.2020.23121.CrossRefPubMedPubMedCentral

Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol Off J Eur Soc Med Oncol. 2020;31(5):P553–555. https://doi.org/10.1016/j.annonc.2020.03.286.CrossRef

Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullian R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–34. https://doi.org/10.1016/S1470-2045(20)30388-0.CrossRefPubMedPubMedCentral

World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd ed. World Health Organization; 2004.

Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017

10.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.CrossRefPubMed

11.

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47. https://doi.org/10.1016/j.ejca.2008.10.026.CrossRefPubMed

12.

Norman G. Likert scales, levels of measurement and the ‘“laws”’of statistics. Adv Health Sci Educ Theory Pract. 2010;15(5):625–32. https://doi.org/10.1007/s10459-010-9222-y.CrossRefPubMed

13.

Caminha I, Távora F, Sousa J, Martins Neto F, Cavalcanti LPG. Impacto Da Pandemia De COVID-19 no diagnóstico de câncer de pulmão no nordeste brasileiro. J Bras Pneumol. 2022;48(6):e20220248.PubMedPubMedCentral

14.

Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, et al. Impact of the COVID-19 pandemic on cancer care: a global collaborative study. JCO Glob Oncol. 2020;6:1428–38.CrossRefPubMed

15.

Brasil. Instituto Brasileiro de Geografia e Estatística. Censo Demográfico. https://www.ibge.gov.br/estatisticas/sociais/rendimento-despesa-e-consumo/22827-censo-demografico-2022.html. Access 1 Mar 2023.

16.

Brasil. Ministério da Saúde. Secretaria de Estado de Saúde. Disponível em: < https://www.saude.mg.gov.br/sus. Access 1 Oct 2022.

17.

Brasil. Sociedade Brasileira de Oncologia clínica. Disponível em: < https://sboc.org.br/noticias/item/1717-nova-lei-obriga-a-realizacao-de-exame-para-diagnostico-de-cancer-em-ate-30-dias. Access 1 Oct 2022.

18.

Brasil. Sociedade Brasileira de Oncologia clínica. Disponível em: https://sboc.org.br/noticias/item/1733-brasil-apresenta-piores-indicadores-no-investimento-em-cancer-se-comparado-a-pares-da-america-latina-revela-pesquisa#:~:text=Diante%20disso%2C%20o%20levantamento%20%E2%80%9CC%C3%A2ncer,suplementar%20(planos%20de%20sa%C3%BAde). Access 1 Oct 2022

19.

Brasil. Ministério da Saúde. Situação alimentar e nutricional no Brasil: excesso de peso e obesidade da população adulta na Atenção Primária à Saúde. 2020.

20.

Sandmæl JA, Sand K, Bye A, Solheim TS, Oldervoll L, Helvik A-S. Nutritional experiences in head and neck cancer patients. Eur J Cancer Care. 2019;28:e13168. https://doi.org/10.1111/ecc.13168.CrossRef

21.

Oliveira KG, von Zeidler SV, Podestá JR, et al. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy. BMC Cancer. 2014;14: 39. https://doi.org/10.1186/1471-2407-14-39.CrossRefPubMedPubMedCentral

22.

Bossi P, Giusti R, Tarsitano A, Airoldi M, De Sanctis V, Caspiani O, et al. The point of pain in head and neck cancer. Crit Rev Oncol/Hematol. 2019;138:51–9. https://doi.org/10.1016/j.critrevonc.2019.04.001.CrossRefPubMed

23.

Park S, Park S, Lee SH, Suh B, Keam B, Kim TM, et al. Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations. Korean J Intern Med. 2016;31(6):1140–9. https://doi.org/10.3904/kjim.2015.062.CrossRefPubMedPubMedCentral

24.

Hochberg U, Elgueta MF, Perez J. Interventional analgesic management of lung cancer pain. Front Oncol. 2017;7: 17. https://doi.org/10.3389/fonc.2017.00017.CrossRefPubMedPubMedCentral

25.

Mahl C, Melo LRS, Almeida MHA, Carvalho CS, Santos LLS, Nunes OS, et al. Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes. Braz Oral Res. 2020;34:e126. https://doi.org/10.1590/1807-3107bor-2020.vol34.0126.CrossRefPubMed

26.

Concepcion J, Yeager M, Alfaro S, Newsom K, Ibrahim J, Bilski T, et al. Trends of cancer screenings, diagnoses, and mortalities during the COVID-19 pandemic: implications and future recommendations. Am Surg. 2022. https://doi.org/10.1177/00031348221091948.CrossRefPubMedPubMedCentral

27.

Marques NP, Silveira DMM, Marques NCT, Martelli DRB, Oliveira EA, Martelli-Júnior H. Cancer diagnosis in Brazil in the COVID-19 era. Seminars in Oncology. 2021;48(2):156–9. https://doi.org/10.1053/j.seminoncol.2020.12.002. ISSN 0093-7754.CrossRefPubMedPubMedCentral

28.

Kasymjanova G, Anwar A, Cohen V, Sultanem K, Pepe C, Sakr L, et al. The impact of COVID-19 on the diagnosis and treatment of lung cancer at a canadian academic center: a retrospective chart review. Curr Oncol. 2021;28:4247–55. https://doi.org/10.3390/curroncol28060360.CrossRefPubMedPubMedCentral

29.

Bersani F, Morena D, Picca F, et al. Future perspectives from lung cancer pre-clinical models: new treatments are coming? Transl lung cancer Res. 2020;9(6):2629–44. https://doi.org/10.21037/tlcr-20-189.CrossRefPubMedPubMedCentral

30.

Lou J, Kooragayala K, Williams JP, Sandilos Georgianna, Butchy MV, Yoon-Flannery KDO et al. The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center. American Journal of Clinical Oncology 45(9):p 381–390, September 2022. | https://doi.org/10.1097/COC.0000000000000936.

31.

Kızılırmak D, Yılmaz Z, Havlucu Y, Çelik P. Impact of the COVID-19 pandemic on diagnosis of lung cancer. SN Compr Clin Med. 2023;5:23. https://doi.org/10.1007/s42399-022-01366-z.CrossRefPubMed

32.

Park JY, Lee YJ, Kim T, Lee CY, Kim HI, Kim JH, et al. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea. BMC Cancer. 2020;20:1040. https://doi.org/10.1186/s12885-020-07544-3.CrossRefPubMedPubMedCentral

33.

Keogh JAJ, Chhor AD, Begum H, Akhtar-Danesh N, Finley C. Impact of the COVID-19 pandemic on non–small-cell lung cancer pathologic stage and presentation. Can J Surg. 2022;65(4):E496. https://doi.org/10.1503/cjs.016721.CrossRefPubMedPubMedCentral

34.

National Cancer Institute. Cancer Stat Facts: Lung and Bronchus. https://seer.cancer.gov/statfacts/html/lungb.html. Access 1 Mar 2023.

35.

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51. https://doi.org/10.1016/j.jtho.2015.09.009.CrossRefPubMed

36.

Solis RN, Mehrzad M, Faiq S, Frusciante RP, Sekhon HK, Abouyared M, et al. The impact of COVID-19 on head and neck cancer treatment: before and during the pandemic. OTO Open. 2021;5(4). https://doi.org/10.1177/2473974X211068075.

37.

Tevetoğlu F, Kara S, Aliyeva C, Yildirim R, Yener HM. Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2021;278:5081–5. https://doi.org/10.1007/s00405-021-06728-2.CrossRefPubMedPubMedCentral

38.

Flynn W, Maqsood R, Maseland T, Montgomery J, Douglas C. Advancing head and neck cancer following the coronavirus disease 2019 pandemic. J Laryngol Otol. 2022:1–7. https://doi.org/10.1017/S0022215122000950.

39.

Popovic M, Fiano V, Moirano G, Chiusa L, Conway DI, Garzino Demo P, Gilardetti M, Iorio GC, Moccia C, Ostellino O, Pecorari G, Ramieri G, Ricardi U, Riva G, Virani S, Richiardi L. The impact of the COVID-19 pandemic on Head and Neck Cancer diagnosis in the Piedmont Region, Italy: interrupted time-series analysis. Front Public Health. 2022;10: 809283. https://doi.org/10.3389/fpubh.2022.809283.CrossRefPubMedPubMedCentral

40.

Burusapat C, Jarungroongruangchai W, Charoenpitakchai M. Prognostic factors of cervical node status in head and neck squamous cell carcinoma. World J Surg Oncol. 2015;13:51. https://doi.org/10.1186/s12957-015-0460-6.CrossRefPubMedPubMedCentral

41.

Clements K, Cowell A, White G, Flynn W, Conway DI, Douglas CM, Paterson C. The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study. Clin Otolaryngol. 2023;48(4):587–94. https://doi.org/10.1111/coa.14048.CrossRefPubMedPubMedCentral

42.

Hoesseini A, Offerman MPJ, van de Wall-Neecke BJ, Sewnaik A, Wieringa MH, Baatenburg de Jong RJ. Physicians’ clinical prediction of survival in head and neck cancer patients in the palliative phase. BMC Palliat Care. 2020;19(1):176. https://doi.org/10.1186/s12904-020-00682-2.CrossRefPubMedPubMedCentral

43.

Peacock HM, De Gendt C, Silversmit G, Nuyts S, Casselman J, Machiels JP, Giusti F, van Gool B, Vander Poorten V, Van Eycken L. Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends. Front Oncol. 2023;13: 1253968. https://doi.org/10.3389/fonc.2023.1253968.CrossRefPubMedPubMedCentral

44.

National Comprehensive Cancer Network. Non-small cell lung cancer (version 2.2023). 2023. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

45.

National Comprehensive Cancer Network. (2022). Head and Neck Cancers (version 1.2023). Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.

46.

Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92–8. https://doi.org/10.1056/NEJMoa011954.CrossRefPubMed

47.

Karahalios A, Baglietto L, Carlin JB, English DR, Simpson JA. A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures. BMC Med Res Methodol. 2012;12: 96. https://doi.org/10.1186/1471-2288-12-96.CrossRefPubMedPubMedCentral

Title: Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil
Authors: Gilson Gabriel Viana Veloso
Flávia Duarte Amaral
Angélica Nogueira-Rodrigues
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: COVID-19
Lung Cancer
Lung Cancer
Lung Cancer
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-024-12255-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Protocol for the development of a Core Outcome Set (COS) for Adolescents and Young Adults (AYAs) with cancer

Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study

Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma

The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer

Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma

Correction: Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer